The combined use of sodium-glucose transport protein 2 (SGLT2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists may offer notable benefits for optimizing cardiovascular and renal outcomes...
LaVarne Burton Credit: American Kidney Fund New patient-focused guidelines from the American Kidney Fund (AKF) are helping individuals with chronic kidney disease (CKD) manage and treat...
Brendon Neuen, MBBS, PhD Credit: X.com Findings from a recent study are providing support for the combined use of sodium-glucose transport protein 2 (SGLT2) inhibitors and...
Participants and procedures From June to August 2022, we conducted a cross-sectional study of employees working in three automobile machining enterprises in Wuxi City, Jiangsu Province....